[go: up one dir, main page]

EE04879B1 - Sünteetilised pindaktiivsed peptiidid ja nende kasutamine sünteetilise surfaktandi valmistamiseks - Google Patents

Sünteetilised pindaktiivsed peptiidid ja nende kasutamine sünteetilise surfaktandi valmistamiseks

Info

Publication number
EE04879B1
EE04879B1 EEP200100413A EEP200100413A EE04879B1 EE 04879 B1 EE04879 B1 EE 04879B1 EE P200100413 A EEP200100413 A EE P200100413A EE P200100413 A EEP200100413 A EE P200100413A EE 04879 B1 EE04879 B1 EE 04879B1
Authority
EE
Estonia
Prior art keywords
synthetic surfactants
preparation
surfactants
synthetic
Prior art date
Application number
EEP200100413A
Other languages
English (en)
Estonian (et)
Inventor
Curstedt Tore
Johansson Jan
J�rnvall Hans
Robertson Bengt
Ventura Paolo
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of EE200100413A publication Critical patent/EE200100413A/xx
Publication of EE04879B1 publication Critical patent/EE04879B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100413A 1999-02-12 2000-02-09 Sünteetilised pindaktiivsed peptiidid ja nende kasutamine sünteetilise surfaktandi valmistamiseks EE04879B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000275A IT1308180B1 (it) 1999-02-12 1999-02-12 Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
PCT/EP2000/001044 WO2000047623A1 (en) 1999-02-12 2000-02-09 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant

Publications (2)

Publication Number Publication Date
EE200100413A EE200100413A (et) 2002-12-16
EE04879B1 true EE04879B1 (et) 2007-08-15

Family

ID=11381859

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100413A EE04879B1 (et) 1999-02-12 2000-02-09 Sünteetilised pindaktiivsed peptiidid ja nende kasutamine sünteetilise surfaktandi valmistamiseks

Country Status (32)

Country Link
US (1) US7053044B1 (xx)
EP (1) EP1151008B1 (xx)
JP (1) JP4754073B2 (xx)
KR (1) KR100645145B1 (xx)
CN (1) CN1221570C (xx)
AR (1) AR022578A1 (xx)
AT (1) ATE280181T1 (xx)
AU (1) AU758735B2 (xx)
BG (1) BG65196B1 (xx)
BR (1) BR0009964A (xx)
CA (1) CA2362507C (xx)
CO (1) CO5241361A1 (xx)
CZ (1) CZ301108B6 (xx)
DE (1) DE60015082T2 (xx)
EA (1) EA004058B1 (xx)
EE (1) EE04879B1 (xx)
ES (1) ES2228473T3 (xx)
GE (1) GEP20032976B (xx)
HU (1) HU228997B1 (xx)
IL (1) IL144842A0 (xx)
IT (1) IT1308180B1 (xx)
MA (1) MA25381A1 (xx)
NO (1) NO20013888D0 (xx)
NZ (1) NZ513451A (xx)
PL (1) PL201084B1 (xx)
PT (1) PT1151008E (xx)
SK (1) SK286428B6 (xx)
TR (1) TR200102308T2 (xx)
UA (1) UA72751C2 (xx)
WO (1) WO2000047623A1 (xx)
YU (1) YU57701A (xx)
ZA (1) ZA200106530B (xx)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
WO2001058423A1 (en) * 2000-02-11 2001-08-16 Altana Pharma Ag Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
ATE349223T1 (de) * 2002-03-01 2007-01-15 Chiesi Farma Spa Pharmazeutische zubereitungen mit verbesserten oberflächeneigenschaften welche ein lungen surfactant und ein polymyxin enthalten
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
BR0317132A (pt) * 2002-12-09 2005-10-25 Chidren S Hospital Medical Ct Métodos de diagnóstico e tratamento de doença pulmonar intersticial
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
AU2004268386A1 (en) * 2003-08-28 2005-03-10 Nycomed Gmbh Use of surfactant preparations for the treatment of surgical adhesions
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US8337815B2 (en) 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
CA2658478C (en) 2006-07-20 2018-02-13 University Of Rochester Synthetic lung surfactant and use thereof
CN103169947B (zh) * 2006-10-13 2014-10-29 奇斯药制品公司 具有改进性质的重组表面活性剂
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8048043B2 (en) 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
TW201035111A (en) 2008-12-23 2010-10-01 Biosource Pharm Inc Antibiotic compositions for the treatment of gram negative infections
EP2475373B1 (en) 2009-09-08 2013-11-13 Chiesi Farmaceutici S.p.A. A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
SG11201406628RA (en) * 2012-04-23 2014-11-27 Chiesi Farma Spa Method and system for the administration of a pulmonary surfactant by atomization
US9074018B2 (en) 2012-11-21 2015-07-07 Chiesi Farmaceutici S.P.A. Reconstituted pulmonary surfactants
EP3106090A1 (en) 2015-06-15 2016-12-21 CHIESI FARMACEUTICI S.p.A. System for effective breath-synchronized delivery of medicament to the lungs
US20180110948A1 (en) 2015-04-22 2018-04-26 Chiesi Farmaceutici S.P.A Method and system for effective breath-synchronized delivery of medicament to the lungs
US11311691B2 (en) 2015-04-28 2022-04-26 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
JP2018514545A (ja) * 2015-04-30 2018-06-07 ユニバーシティ オブ ブレーメン 医療用および美容用の新規な皮膚ケア製造物
RU2019105531A (ru) 2016-07-28 2020-08-28 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Способ и система для доставки лекарственного препарата в форме аэрозоля
BR112019008169A2 (pt) 2016-10-26 2019-07-09 Chiesi Farm Spa dispositivo para facilitar o posicionamento de um cateter, sistema para entrega de um medicamento em aerossol por meio de um cateter, método para utilização de um dispositivo e kit
CN110099695B (zh) 2016-12-22 2022-01-25 奇斯药制品公司 用于治疗进展性bpd的包含肺表面活性物质和类固醇的治疗组合
TW201927286A (zh) 2017-12-15 2019-07-16 義大利商凱西製藥公司 用於噴霧投藥之包含肺表面張力素的藥學調配物
WO2019115771A1 (en) 2017-12-15 2019-06-20 Pari Pharma Gmbh Nebuliser system, holding system, combination comprising nebuliser system and holding system, and aerosol administration method
MX2020011127A (es) 2018-04-23 2021-01-15 Chiesi Farm Spa Combinacion terapeutica que comprende agente tensioactivo pulmonar y esteroide para la profilaxis de displasia broncopulmonar (bpd).
EP3666316A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3666315A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3843105A1 (en) 2019-12-23 2021-06-30 PARI Pharma GmbH Control device for aerosol nebulizer system
WO2021151853A1 (en) 2020-01-28 2021-08-05 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
CN114159546B (zh) * 2021-12-20 2024-06-04 北京双鹤润创科技有限公司 新一代合成肺表面活性物质制剂及其临床应用
EP4411745A1 (en) 2023-02-01 2024-08-07 Pari Medical Holding GmbH Medical evaluation method, aerosol nebulizer and medical evaluation system
EP4464236A1 (en) 2023-05-15 2024-11-20 Pari Medical Holding GmbH Method of operating an inhalation device, inhalation device and inhalation device system for providing inhalation process feedback
EP4464354A1 (en) 2023-05-15 2024-11-20 Pari Medical Holding GmbH Method of operating an inhalation device, inhalation device and inhalation device system for providing inhalation process/breath guiding

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
US5827825A (en) * 1993-12-08 1998-10-27 Tokyo Tanabe Company Ltd. Synthetic peptide, lung surfactant containing the same and remedy for respiratory distress syndrome
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Also Published As

Publication number Publication date
ZA200106530B (en) 2002-10-14
SK286428B6 (sk) 2008-09-05
ITMI990275A1 (it) 2000-08-12
IL144842A0 (en) 2002-06-30
NO20013888L (no) 2001-08-09
CN1221570C (zh) 2005-10-05
SK11442001A3 (sk) 2001-12-03
CZ20012876A3 (cs) 2002-06-12
US7053044B1 (en) 2006-05-30
KR100645145B1 (ko) 2006-11-10
PL349785A1 (en) 2002-09-09
AU3279300A (en) 2000-08-29
JP2002541062A (ja) 2002-12-03
BG105764A (en) 2002-03-29
EA004058B1 (ru) 2003-12-25
NZ513451A (en) 2003-05-30
AR022578A1 (es) 2002-09-04
CA2362507A1 (en) 2000-08-17
ES2228473T3 (es) 2005-04-16
CO5241361A1 (es) 2003-01-31
DE60015082T2 (de) 2006-02-09
HUP0200141A2 (en) 2002-06-29
ATE280181T1 (de) 2004-11-15
PL201084B1 (pl) 2009-03-31
YU57701A (sh) 2003-07-07
WO2000047623A1 (en) 2000-08-17
DE60015082D1 (de) 2004-11-25
HU228997B1 (en) 2013-07-29
EA200100749A1 (ru) 2002-02-28
CA2362507C (en) 2012-01-03
EP1151008A1 (en) 2001-11-07
GEP20032976B (en) 2003-05-27
MA25381A1 (fr) 2002-04-01
UA72751C2 (en) 2005-04-15
BR0009964A (pt) 2002-04-09
NO20013888D0 (no) 2001-08-09
KR20010101904A (ko) 2001-11-15
BG65196B1 (bg) 2007-06-29
PT1151008E (pt) 2005-01-31
IT1308180B1 (it) 2001-12-07
CZ301108B6 (cs) 2009-11-11
HK1042500A1 (en) 2002-08-16
TR200102308T2 (tr) 2002-04-22
EP1151008B1 (en) 2004-10-20
EE200100413A (et) 2002-12-16
HUP0200141A3 (en) 2002-09-30
AU758735B2 (en) 2003-03-27
JP4754073B2 (ja) 2011-08-24
CN1340060A (zh) 2002-03-13

Similar Documents

Publication Publication Date Title
EE200100413A (et) Sünteetilised pindaktiivsed peptiidid ja nende kasutamine sünteetilise surfaktandi valmistamiseks
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
EE05210B1 (et) Suhkurt?vevastane preparaat ja selle kasutamine meditsiinis
PT1270565E (pt) Furano-2-sulfonamida 4-substituida e sua utilizacao na preparacao de derivados de sulfonilureia
EE04565B1 (et) Adamantaani derivaadid, nende saamine ja kasutamine
BR0010385B1 (pt) concentrado lÍquido para preservar cosmÉticos e uso do mesmo.
EE04452B1 (et) Farmatseutiliselt aktiivne morfolinool ja selle kasutamine
EE05067B1 (et) Aminoproplfosfiinhapped ning nende kasutamine meditsiinis
EE200200414A (et) Dihüdro-1,3,5-triasiinamino derivaadid ja nende kasutamine ravis
ID26340A (id) Kapsul ganda dengan penggunaan bahan-bahan aktif dalam berbagai macam pengobatan
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
FI982684L (fi) Uusi bioaktiivinen tuote ja sen käyttö
ID22566A (id) Penggunaan nanodispersi dalam formulasi akhir kosmetik
ATE272998T1 (de) Hautreinigungszusammensetzung mit verbesserter stabilität
FI972245A0 (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
PT1274308E (pt) Combinacoes de substancias activas com propriedades insecticidas e acaricidas
NO20025510L (no) Dibenzoazulen-derivater samt anvendelse derav
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
PT1025100E (pt) Derivados de tetra-hidropiridopirimidona substituidos na posicao 3 sua preparacao e sua utilizacao
FI982682A0 (fi) Uusi komposiitti ja sen käyttö
IT1291823B1 (it) Composti pseudo-peptidici, loro preparazione ed uso in formulazioni farmaceutiche
IL154485A0 (en) Lipo-or amphiphilic scintillators and their use in assays
GB2351459B (en) Improvements in and relating to the application of materials
FI964854L (fi) Hydroksitioasetamidien valmistus ja niiden käyttö bentsotiofeenien synteesissä

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231